Asklepios Group Reports Stable Performance in Q1 2025

Asklepios Kliniken GmbH & Co. KGaA reported stable business performance in the first quarter of 2025. From January to March, Asklepios healthcare facilities treated 954,522 patients, marking a 3.8% increase from the same period the previous year. Inpatient treatments saw a marginal change, while outpatient care rose to 757,393 from the previous year's 723,235.

The group's revenue increased by 10.2%, reaching EUR 1.56 billion. Consolidated net income totaled EUR 22.5 million, improving from EUR 18.5 million in the previous year. The EAT margin was slightly up at 1.4%. Investments in Q1 2025 were EUR 69.5 million.

As of March 31, 2025, the financial position remained stable with an equity capital ratio of 30.4% and a net debt ratio of 2.8x. These figures indicate a strong footing in the healthcare sector.